Clearmind Medicine Inc.
CMND · NASDAQ
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,929 | $7,393 | $104,503 | $67,668 |
| - Cash | $6,574 | $5,428 | $176 | $4,599 |
| + Debt | $53 | $0 | $52 | $0 |
| Enterprise Value | -$592 | $1,965 | $104,379 | $63,068 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$27 | -$56 | -$113 | -$3 |
| % Margin | – | – | – | – |
| EBITDA | -$7,982 | -$8,711 | -$8,486 | -$3,674 |
| % Margin | – | – | – | – |
| Net Income | -$5,255 | -$11,955 | -$9,411 | -$3,720 |
| % Margin | – | – | – | – |
| EPS Diluted | -67.6 | -1,703.2 | -8,688 | -4,812 |
| % Growth | 96% | 80.4% | -80.5% | – |
| Operating Cash Flow | -$4,859 | -$6,301 | -$5,084 | -$2,835 |
| Capital Expenditures | $0 | $0 | -$8 | -$231 |
| Free Cash Flow | -$4,859 | -$6,301 | -$5,091 | -$3,066 |